BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11222981)

  • 1. Elicitation of predictable immune responses by using live bacterial vectors.
    Drabner B; Guzmán CA
    Biomol Eng; 2001 Mar; 17(3):75-82. PubMed ID: 11222981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
    Medina E; Guzmán CA
    Vaccine; 2001 Feb; 19(13-14):1573-80. PubMed ID: 11166877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F; Ulmer JB
    J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances with recombinant bacterial vaccine vectors.
    Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
    Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
    Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
    Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G; Spreng S; Gentschev I; Goebel W
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation.
    Beyer T; Herrmann M; Reiser C; Bertling W; Hess J
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):287-302. PubMed ID: 12455402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A; zur Lage S; Garbe AI; Chakraborty T; Weiss S
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):341-9. PubMed ID: 10727890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Daniels J; Hess J; Kaufmann SH; Goebel W
    J Biotechnol; 2000 Sep; 83(1-2):19-26. PubMed ID: 11000455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV.
    Vecino WH; Morin PM; Agha R; Jacobs WR; Fennelly GJ
    Immunol Lett; 2002 Jul; 82(3):197-204. PubMed ID: 12036602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.